Psychosis linked to ADHD medication on the rise, doctors warn
Psychiatrists in Australia have raised concerns about a rising incidence of psychosis among adults taking stimulant medication for Attention Deficit Hyperactivity Disorder (ADHD). Dr. Pramudie Gunaratne, Executive Director of the Australian Society of Psychiatrists, noted that while such side effects were rare a decade ago, they are becoming a more common clinical presentation as prescription rates surge. Research indicates that the number of adults receiving treatment for ADHD has increased more than sixfold since 2017, driven by heightened awareness of the condition. Dr. Matthew Large, a psychiatrist at the University of New South Wales, reported treating multiple recent cases where patients developed paranoia or hallucinations, attributing some instances to incorrect diagnoses or misuse of medication. Experts emphasize that while the risk remains low, it is not negligible, and current prescribing practices may be moving faster than available safety data for adult populations.
Australian psychiatrists have issued a warning regarding a rising trend of psychosis among patients taking stimulant medication for attention deficit hyperactivity disorder. The condition manifests through symptoms such as paranoia, hallucinations, and delusional beliefs. While these drugs remain transformative for many individuals with ADHD, medical experts caution that they can trigger severe psychiatric episodes in rare instances. The increase in cases correlates with a surge in diagnoses and prescriptions across the country. Dr. Pramudie Gunaratne, the executive director of the Australian Society of Psychiatrists, noted that stimulant-induced psychosis was uncommon a decade ago. She described the phenomenon as becoming a more regular clinical presentation today. According to Dr. Gunaratne, the expansion in the population prescribed these medications logically leads to a proportional increase in adverse reactions. She highlighted specific behaviors that elevate risk, including taking doses higher than prescribed, using the medication without medical supervision, and obtaining stimulants from friends. Research conducted by the University of New South Wales indicates that the number of adults receiving treatment for ADHD has increased by more than six times since 2017. This growth follows a sharp rise in diagnostic rates driven by greater public awareness of the neurodevelopmental condition. Estimates suggest that between two and six percent of Australian adults have ADHD. Dr. Gunaratne explained that stimulant medications alter brain chemistry. She emphasized that, like all pharmaceuticals, they carry significant risks. Even when patients adhere strictly to prescribed dosages and lack known risk factors, a rare but genuine possibility of psychosis exists. She observed that affected individuals often lack insight into their changing behavior. Consequently, family members or colleagues frequently detect that the patient's thinking or actions have become out of character before the individual realizes the issue. Dr. Matthew Large, a conjoint professor at UNSW and a Sydney-based psychiatrist, reports treating an increasing volume of patients suffering from psychosis linked to ADHD medication. In the past year alone, he managed four such cases. One involved a young woman prescribed stimulants for inattention, which Dr. Large identified as stemming from trauma rather than ADHD. He stated that the patient required treatment for post-traumatic stress disorder instead. Another case involved a high-achieving student who fabricated ADHD symptoms to obtain medication intended to boost academic performance. This patient developed psychosis after voluntarily increasing their dosage. Dr. Large criticized current practices, stating that too few patients are adequately informed about the risk of psychosis prior to commencing treatment. The expert further argued that safety data does not fully support current prescribing trends. While studies on stimulants in children indicate that only a small proportion develop psychosis, it remains unclear if adult populations face similar low-risk profiles. Dr. Large asserted that clinical practice has moved ahead of the available safety evidence. The underlying mechanism involves excessive dopamine transmission in the brain, a process intensified by stimulant use. Individuals experiencing psychosis are typically hospitalized, where they receive antipsychotic medication, therapy, and social support. Dr. Large described a single psychotic episode as a profoundly significant life event. Patients lose contact with reality, often engage in deeply embarrassing acts, and may encounter legal troubles. Associate Professor Mark Putland, the Victoria branch chair of the Australasian College for Emergency Medicine, confirmed that misuse of ADHD medication triggers psychosis in some patients. However, he noted that others develop the condition even when using the medication as directed. He characterized the situation as a serious health problem from both addiction and mental health perspectives, describing psychosis as the extreme endpoint of the issue. Sources indicate that the combination of ADHD medication with other substances contributes to the risk, though the text cuts off before detailing specific interactions. The medical community emphasizes that while the drugs offer substantial benefits for managing ADHD, the potential for severe psychiatric side effects demands careful monitoring and informed consent. The discrepancy between the rapid increase in prescriptions and the limited long-term safety data for adults continues to concern clinicians. Patients are advised to seek immediate help if they experience changes in mood or perception. The healthcare system faces challenges in balancing accessibility to effective treatments with the need to prevent avoidable harm. As diagnosis rates continue to climb, the burden on emergency services and psychiatric units grows. Doctors urge patients to maintain open communication with their prescribers regarding any unusual symptoms. The consensus among the cited specialists is that vigilance is required as the user base expands significantly.
Psychiatrists in Australia have raised concerns about a rising incidence of psychosis among adults taking stimulant medication for Attention Deficit Hyperactivity Disorder (ADHD). Dr. Pramudie Gunaratne, Executive Director of the Australian Society of Psychiatrists, noted that while such side effects were rare a decade ago, they are becoming a more common clinical presentation as prescription rates surge. Research indicates that the number of adults receiving treatment for ADHD has increased more than sixfold since 2017, driven by heightened awareness of the condition. Sydney psychiatrist Dr. Matthew Large reported treating multiple recent cases where patients developed paranoia or hallucinations, attributing some instances to incorrect diagnoses or misuse of medication. Experts emphasize that while the risk remains rare, it is significant enough to warrant clearer communication of potential dangers to patients prior to starting treatment.
Bias read (Center): The article maintains a neutral tone by citing medical experts on both the prevalence of the issue and the specific risks involved without employing loaded language or advocating for specific regulatory changes.
Psychiatrists in Australia have raised concerns about a rising incidence of psychosis among adults taking stimulant medication for Attention Deficit Hyperactivity Disorder (ADHD). Dr. Pramudie Gunaratne, Executive Director of the Australian Society of Psychiatrists, noted that while such side effects were rare a decade ago, they are becoming a more common clinical presentation as prescription rates surge. Research indicates that the number of adults receiving treatment for ADHD has increased more than sixfold since 2017, driven by heightened awareness of the condition. Dr. Matthew Large, a psychiatrist at the University of New South Wales, reported treating multiple recent cases where patients developed paranoia or hallucinations, attributing some instances to incorrect diagnoses or misuse of medication. Experts emphasize that while the risk remains low, it is not negligible, and current prescribing practices may be moving faster than available safety data for adult populations.
Bias read (Center): The article relies exclusively on expert medical testimony regarding clinical observations and statistical trends, presenting balanced warnings about drug risks without engaging in partisan political debate or ideological framing.
How each side covered it
The same event, grouped by the political lean of the outlets covering it.
progressive
center
conservative
β
How each side covered it
Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.